https://clinicaltrials.gov/ct2/show/NCT03895996
Safety, Tolerability and Potential Efficacy of AVT001 in Patients With Type 1 Diabetes
Study Type : Interventional
Estimated Enrollment : 24 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Phase 1 / 2 Double-Blind, Randomized, Placebo Controlled Study of Safety, Tolerability and Potential Efficacy of AVOTRES Cell-Based Therapy (AVT001) in Patients With Type 1 Diabetes
Estimated Study Start Date : June 2019
Estimated Primary Completion Date : November 2020
Estimated Study Completion Date : June 2022
